uniQure N.V. Derivative, Gain (Loss) on Derivative, Net
uniQure N.V. (QURE) reported Derivative, Gain (Loss) on Derivative, Net of $0 for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-02.
Discontinued › Income Statement › Other Income
us-gaap:DerivativeGainLossOnDerivativeNet · last filed 2022-11-02
- uniQure N.V. derivative, gain (loss) on derivative, net for the quarter ending 2022-09-30 was $0.00.
- uniQure N.V. derivative, gain (loss) on derivative, net for the quarter ending 2022-06-30 was $17.14M, a 147.01% increase year-over-year.
- uniQure N.V. derivative, gain (loss) on derivative, net for the quarter ending 2022-03-31 was $7.36M, a 37.70% increase year-over-year.
- uniQure N.V. derivative, gain (loss) on derivative, net for the quarter ending 2021-12-31 was $31.34M.
- uniQure N.V. derivative, gain (loss) on derivative, net for fiscal 2021 was $31.34M.
- uniQure N.V. derivative, gain (loss) on derivative, net for fiscal 2020 was -$14.73M.
- uniQure N.V. derivative, gain (loss) on derivative, net for fiscal 2019 was -$891.00K, a 116.19% decline from fiscal 2018.
- uniQure N.V. derivative, gain (loss) on derivative, net for fiscal 2018 was $5.50M.
| Period end | Derivative, Gain (Loss) on Derivative, Net 3 month | Derivative, Gain (Loss) on Derivative, Net 6 month | Derivative, Gain (Loss) on Derivative, Net 9 month | Derivative, Gain (Loss) on Derivative, Net 9 month as first filed | Derivative, Gain (Loss) on Derivative, Net 12 month |
|---|---|---|---|---|---|
| 2022-09-30 | $0.00 10-Q · filed 2022-11-02 | $17.14M derived: sum of 2 quarters · filed 2022-11-02 | $600.00K 10-Q · filed 2022-11-02 | $55.83M derived: sum of 4 quarters · filed 2022-11-02 | |
| 2022-06-30 | $17.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $24.49M 10-Q · filed 2022-08-08 | $55.83M derived: sum of 3 quarters · filed 2022-08-08 | $55.83M derived: sum of 4 quarters · filed 2022-11-02 | |
| 2022-03-31 | $7.36M 10-Q · filed 2022-05-02 | $38.69M derived: sum of 2 quarters · filed 2022-05-02 | $38.69M derived: sum of 3 quarters · filed 2022-11-02 | $45.63M derived: sum of 4 quarters · filed 2022-11-02 | |
| 2021-12-31 | $31.34M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $31.34M derived: sum of 2 quarters · filed 2022-11-02 | $38.27M derived: sum of 3 quarters · filed 2022-11-02 | $31.34M 10-K · filed 2022-02-25 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-02 | $6.94M derived: sum of 2 quarters · filed 2022-11-02 | $0.00 10-Q · filed 2022-11-02 | $23.24M 10-Q · filed 2021-10-25 | $5.31M derived: sum of 4 quarters · filed 2022-11-02 |
| 2021-06-30 | $6.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $12.28M 10-Q · filed 2022-08-08 | $5.31M derived: sum of 3 quarters · filed 2022-08-08 | -$3.36M derived: sum of 4 quarters · filed 2022-08-08 | |
| 2021-03-31 | $5.34M 10-Q · filed 2022-05-02 | -$1.63M derived: sum of 2 quarters · filed 2022-05-02 | -$10.30M derived: sum of 3 quarters · filed 2022-05-02 | -$14.21M derived: sum of 4 quarters · filed 2022-05-02 | |
| 2020-12-31 | -$6.97M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | -$15.64M derived: sum of 2 quarters · filed 2022-02-25 | -$19.55M derived: sum of 3 quarters · filed 2022-02-25 | -$14.73M 10-K · filed 2022-02-25 | |
| 2020-09-30 | -$8.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-25 | -$12.58M derived: sum of 2 quarters · filed 2021-10-25 | -$7.76M 10-Q · filed 2021-10-25 | -$15.34M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-06-30 | -$3.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-26 | $908.00K 10-Q · filed 2021-07-26 | -$6.67M derived: sum of 3 quarters · filed 2022-02-25 | -$369.00K derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-03-31 | $4.82M 10-Q · filed 2021-05-10 | -$2.76M derived: sum of 2 quarters · filed 2022-02-25 | $3.55M derived: sum of 3 quarters · filed 2022-02-25 | $2.11M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2019-12-31 | -$7.58M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | -$1.28M derived: sum of 2 quarters · filed 2022-02-25 | -$2.71M derived: sum of 3 quarters · filed 2022-02-25 | -$891.00K 10-K · filed 2022-02-25 | |
| 2019-09-30 | $6.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | $4.87M derived: sum of 2 quarters · filed 2020-10-27 | $6.69M 10-Q · filed 2020-10-27 | ||
| 2019-06-30 | -$1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $386.00K 10-Q · filed 2020-07-30 | |||
| 2019-03-31 | $1.82M 10-Q · filed 2020-04-29 | ||||
| 2018-12-31 | $5.50M 10-K · filed 2021-03-01 | ||||
| 2017-12-31 | -$4.22M 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |